Clinical trial / 2006
Oral broccoli sprout glucosinolates and isothiocyanates taken every 8 hours for 7 days showed no significant toxicities in healthy volunteers.
Healthy volunteers in three cohorts received oral broccoli sprout extracts containing glucosinolates (25 or 100 micromol) or isothiocyanates (25 micromol) or placebo every 8 hours for 7 days following a crucifer-free diet. Mean cumulative excretion of dithiocarbamates as a fraction of dose was 17.8 +/- 8.6% for 25 micromol glucosinolate, 19.6 +/- 11.7% for 100 micromol glucosinolate, and 70.6 +/- 2.0% for 25 micromol isothiocyanate. Evaluation of 32 hematology and chemistry tests, including liver transaminases and thyroid function markers, revealed no significant or consistent subjective or objective toxicities associated with sprout extract ingestion.
- Study type
- Double-blind, placebo-controlled randomized phase I trial
- Who was studied
- 12 healthy in-patient volunteers across three cohorts (3 treated and 1 placebo per cohort)
- What was measured
- Safety, tolerance (including liver and thyroid function tests), and dithiocarbamate excretion
THE PAPER
Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study.
Shapiro TA, Fahey JW, Dinkova-Kostova AT, Holtzclaw WD, Stephenson KK, Wade KL, Ye L, Talalay P. Nutr Cancer, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.